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The emergence of fluoroquinolone resistance in nosocomial pathogens has restricted the clinical 24 efficacy of this antibiotic class. In Acinetobacter baumannii, the majority of clinical isolates 25 now show high-level resistance due to mutations in gyrA (DNA gyrase) and parC (Topo IV). To 26 investigate the molecular basis for fluoroquinolone resistance, an exhaustive mutation analysis 27 was performed in both drug sensitive and resistant strains to identify loci that alter the sensitivity 28 of the organism to ciprofloxacin. To this end, parallel fitness tests of over 60,000 unique 29 insertion mutations were performed in strains with various alleles in genes encoding the drug 30 targets. The spectrum of mutations that altered drug sensitivity was found to be similar in the 31 drug sensitive and double mutant gyrAparC background having resistance alleles in both genes. 32
In contrast, introduction of a single gyrA resistance allele, resulting in preferential poisoning of 33
Topo IV by ciprofloxacin, led to extreme alterations in the insertion mutation fitness landscape. 34
The distinguishing feature of preferential Topo IV poisoning was induction of DNA synthesis in 35 the region of two endogenous prophages, which appeared to occur in situ. Induction of the 36 selective DNA synthesis in the gyrA background was also linked to enhanced activation of SOS 37 response and heightened transcription of prophage genes relative to that observed in either the 38 WT or gyrAparC double mutants. Therefore, the accumulation of mutations that result in the 39 stepwise evolution of high ciprofloxacin resistance is tightly connected to suppression of 40 hyperactivation of the SOS response and endogenous prophage DNA synthesis. 41 42 fluoroquinolone resistance in many bacteria (13) . Of the RND systems in A. baumannii, native 90 levels of AdeIJK in wild-type (WT) strains lacking acquired mutations have been shown to 91 provide intrinsic resistance to fluoroquinolones (12) . Whether regulated production of other 92 efflux systems provides intrinsic fluoroquinolone resistance is less clear. 93
Another major strategy for intrinsic fluoroquinolone resistance is activation of DNA 94 damage repair pathways (14) . DNA lesions caused by fluoroquinolone intoxication are processed 95 to single-stranded DNA and subsequently induce the SOS repair response, resulting in de-96 repression of many genes involved in DNA recombination and repair (15). Knockout mutations 97 in a variety of DNA repair genes result in increased fluoroquinolone susceptibility in several 98 species (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In certain cases, the SOS response also induces mobile genetic elements that 99 carry antibiotic resistance or toxin genes, potentially influencing the spread of resistance or 100 virulence traits (25). The A. baumannii SOS repair response is non-canonical, lacking clear 101 orthologs of many major players in other systems (26) and is characterized by a phenotypically 102 variable response within cell populations (27) . Inactivation of RecA, a central protein mediating 103 DNA recombinational repair and SOS induction, or the RecBCD Exonuclease V complex 104 responsible for double-strand break repair, greatly raises fluoroquinolone sensitivity in A. 105 baumannii (28, 29) . The role of the SOS response and other DNA repair systems, however, in 106 the development of antibiotic resistance in this organism is largely unknown. 107
In this study, we present the results of a comprehensive screen for determinants of 108 intrinsic resistance to the fluoroquinolone antibiotic ciprofloxacin in A. baumannii. We 109 hypothesized that the ciprofloxacin resistome varies depending on the drug target (DNA gyrase 110 or Topo IV) that is preferentially poisoned, which is determined by possession of WT or resistant 111 versions of the enzymes. We therefore performed parallel screens with isogenic A. baumannii 112 strains containing sensitive or resistant gyrA and parC alleles to uncover the influence of target 113 selectivity on the intrinsic resistance landscape. This analysis led to the surprising discovery that 114 endogenous prophage activation by fluoroquinolones shows dramatic dependence on the 115 availability of a sensitive parC allele. 116 117 118
Results

119
Identification of Acinetobacter baumannii loci that confer altered sensitivity to 120 ciprofloxacin. As part of a largescale effort to characterize the molecular nature of intrinsic 121 resistance of Acinetobacter baumannii to antimicrobials, we identified the entire spectrum of 122 insertion mutations that cause altered sensitivity to the fluoroquinolone antibiotic ciprofloxacin 123 during growth in bacteriological culture. A number of studies have demonstrated that mutations 124 that cause antibiotic hypersensitization in strain backgrounds lacking demonstrable resistance 125 loci exhibit these effects independently of whether there are target site resistance mutations or 126 antibiotic-inactivating enzymes present in the strains being interrogated (20, 30) . We wanted to 127 test this model by first identifying loci that confer intrinsic resistance in a strain background 128 having intact drug targets, and then comparing them with intrinsic resistance loci identified in 129 strains having drug target mutations in DNA gyrase or Topo IV. For this work, we will refer to 130 lesions resulting in lowered resistance to the antibiotic as ciprofloxacin-hypersensitizing 131 mutations in each strain background, and the genes harboring these mutations as loci of 132 hypersensitization. 133
To identify ciprofloxacin hypersensitization loci, ciprofloxacin concentrations below the 134 minimal inhibitory concentration (MIC) ( Table 1 ) were identified that resulted in growth rates of 135 A. baumannii ATCC17978 in rich broth that were between 60-80% of that observed without 136 antibiotics (Fig. 1A) . Three of these concentrations were chosen for further analysis (0.05, 0.075 137 and 0.09-0.10 μg/ml) to determine the relative fitness of insertion mutations when subjected to 138 each of the antibiotic stress conditions. Multiple independent Tn10 insertion pools (7 pools for 139 0.05 µg/ml, and 11 pools for 0.075 and 0.09-0.10 µg/ml ciprofloxacin) having between 6,000 140 and 18,000 individual insertions (60,000 separate sites in all) were grown in broth in the 141 presence or absence of ciprofloxacin for approximately 8 generations. DNA samples taken from 142 the initial time point prior to growth (t 1 ) and the final timepoint after 8 generations growth (t 2 ) 143
were prepared from each of the pools. The insertion sites were then amplified preferentially and 144 subjected to high density sequencing, followed by determining the relative fitness of each 145 insertion mutant based on density of reads (Materials and Methods; Data Set S1). Using 146 accepted strategies, the fitness of each insertion mutant strain was calculated relative to the entire 147 pool (31). To standardized results across experiments, fitness values were normalized to 148 insertions found in 18 neutral sites located in pseudogenes or endogenous transposon-related 149 genes throughout the genome ("neutral" mutants), to allow an accurate quantitation of the 150 representation of mutants relative to control insertions predicted to have no effect on growth 151 (32). The normalized data from the individual insertion mutations were aggregated for each 152 gene to calculate a mean fitness level for the entire spectrum of mutations found within a 153 particular gene. The complete datasets were then displayed on an individual gene level as the 154 growth rate changes for mutations relative to the growth rate of the entire pool (Fig. 1B) . 155
Candidate mutants were identified that showed lower (hypersensitizing loci) or higher fitness 156 levels based on the criteria that the False Discovery Rate (FDR) q value was <0.05, a change in 157 fitness (W diff ) was >10%, and fitness value was derived from at least 3 independent insertion 158 mutants ((33); Materials and Methods). 159
Small increases in the dose of ciprofloxacin greatly increased the spectrum of 160 ciprofloxacin hypersensitivity loci ( Fig. 1B; black) . At a dose causing approximately 20% 161 growth inhibition, mutations in only 10 genes passed the criteria for lower fitness relative to the 162 rest of the pool in the presence of the drug. These included insertions in: two genes involved in 163 double strand break repair (recB and ruvA, encoding subunits of exonuclease V and the Holiday 164 junction helicase); the major egress pump which is often found overproduced in clinical strains 165 having high level fluoroquinolone resistance (adeIJK); and ctpA, a periplasmic protease shown 166 to be a target of mutations that augment -lactam resistance in strains lacking the bfmRS global 167 regulatory system (34) (Data Set S1). Increasing the drug dose had two effects on expanding the 168 spectrum of hypersensitivity loci. First, although the number of hypersensitivity loci that 169 contribute to the enzymology of DNA repair increased from 2 members to 20 in the high dose 170 regimen, this expansion largely involved hitting additional subunits of the same complexes or 171 backup systems of the enzymes identified in the low dose regimen (recBCD, sbcCD, ruvABC) 172 (Data Set S1). This emphasizes the importance of protecting against double strand breaks caused 173 by fluoroquinolone-poisoned DNA gyrase (35). Secondly, increasing dose resulted in 174 hypersensitivity loci in cell envelope integrity proteins, additional protein-processing enzymes, 175 and a MATE class proton-driven efflux pump (abeM) shown to export ciprofloxacin and other 176 antibiotic compounds when cloned in E. coli (36) (Data Set S1; Fig. 1C ). Interestingly, 177 increasing the drug dose did not implicate the two other major RND efflux systems in protecting 178 from ciprofloxacin stress even though they are known to provide low-level resistance after 179 overproduction (12). This may be explained by the fact that the adeIJK system is the only RND 180 egress pump known to have a high basal level of expression in WT strains lacking acquired 181 resistance mutations, while the inducing signals for the other systems have not been identified 182 (12) . Strikingly, at the higher drug doses, mutations in adeN, which encodes the negative 183 regulator of adeIJK, increased the fitness of A. baumannii relative to the rest of the pool (Data 184 Set S1). These data argue strongly that the primary efflux pumps involved in intrinsic protection 185 from fluoroquinolone stress are AdeIJK and AbeM. 186
In addition to hypersensitivity loci, mutations were identified at the highest drug dose that 187 resulted in increased fitness relative to the insertion pool ( analysis, the magnitude of the effects predicted, and differing functional categories (Fig. 1C) . For 204 instance, mutations in the egress pump-encoding adeIJK showed extremely poor fitness and 205 were rarely recovered after growth in ciprofloxacin ( Fig. 2A) . Similarly, the insertions in ctpA 206 showed very low fitness. In contrast, although ciprofloxacin treatment lowered fitness for 207 mutants lacking the penicillin binding protein PBP1A, these mutations clearly had weaker effects 208 in the Tn-seq analysis. When this set of targeted mutants was analyzed further, loss of adeIJK, 209 recN, ctpA and pbp1A all resulted in heightened drug sensitivity (Fig. 2B) . In contrast, deletion 210 of gidA-encoded tRNA modification enzyme resulted in enhanced fitness in the presence of 211 ciprofloxacin, with increased yields in broth cultures exposed to 0.15 µg/ml of antibiotic (Fig.  212 
2B). 213
Identification of loci that result in altered ciprofloxacin sensitivity in A. baumannii 214 target site mutants. A majority of the current clinical isolates of A. baumannii are resistant to 215 fluoroquinolones, and these isolates commonly have the gyrA(S81L) and parC(S84L) target site 216 mutations that lower the affinity for these antibiotics (41). To determine the spectrum of 217 insertions that cause altered sensitivity to ciprofloxacin in strains having resistance alleles, 218 gyrA(S81L) (hereafter referred to as gyrA R ) and gyrA(S81L) parC(S84L) (referred to as gyrA R 219 parC R ) mutants were generated, and each strain was subjected to Tn10 mutagenesis. Pools 220 totaling more than 70,000 insertion mutations were constructed in each background. Insertion 221 pools were challenged with ciprofloxacin, using drug concentrations below the MIC (Table 1)  222 that resulted in 30-40% growth inhibition for each strain (1.1μg/ml for gyrA R ; 13-14 μg/ml for 223 gyrA R parC R double mutant; Fig. 3A ). The spectrum of insertions that resulted in 224 hypersensitivity to ciprofloxacin in the gyrA R parC R double mutant strain backgrounds was very 225 similar to the WT (Fig. 3C,D) . In fact, almost every ciprofloxacin hypersensitive locus in the 226 double mutant background was identified previously in the WT (green circles, Fig. 3C ; Data Sets 227 S1 and S3). In addition, there was a number of hypersensitivity loci identified in the WT pools 228 that did not pass the discovery criteria in the double mutant (FDR<0.05; W diff >0.1). A number of 229 these below-threshold candidates in the gyrA R parC R double mutant strain background encoded 230 subunits of the proteins identified as ciprofloxacin-hypersensitive loci (green circles, Fig. 3C ; 231 Data Set S3). These results are similar to what we had observed in our graded series of drug 232 treatments of insertion pools in the WT strain, indicating that the results from the WT strain and 233 the drug resistant double mutant are largely the same. 234
The results from the gyrA R single mutant background, however, diverged greatly from the 235 WT and the gyrA R parC R double mutant ( then prepared from each of the cultures and subjected to whole genome sequencing using an 260 average read length of 100 bp. The density of these individual short reads was plotted as a 261 function of the chromosomal coordinates, to identify regions of chromosomal DNA that were 262 selectively amplified in the presence of drug (Fig. 4B) . Analysis of the gyrA R single mutant 263 showed hyperamplification of prophages 1 and 3, with read density in the prophage regions 264 observed as a function of drug concentration. In contrast, there was little evidence of this 265 selective amplification in the WT strain, while the gyrA R parC R largely reversed these effects. 266
Consistent with the Tn-seq data, there was amplification of DNA extending beyond the 267 prophage-chromosomal DNA junction, indicating that drug-driven DNA synthesis was initiated 268 in situ and continued beyond the ends of the prophages into adjacent chromosomal DNA (Fig.  269   4C ). We conclude that in a gyrA R background, selective blockage of the parC-encoded Topo IV 270 protein resulted in DNA synthesis induction in these two prophage regions. 271
To determine if transcription of prophage genes is specifically amplified in the gyrA R 272 mutant relative to the WT, the two strains were grown in triplicate cultures in two concentrations 273 of antibiotic for 3.5 hours that gave between 40-70% growth inhibition over approximately 7 274 generations (Fig. 5A) . The cells were then extracted, subjected to RNAtag-seq analysis (42), and 275 the ratio of transcription for each gene in the presence/absence of ciprofloxacin was displayed as 276 a function of chromosomal map position (Fig. 5B , Data Set S4). There was preferential 277 amplification of transcription of prophage genes in the presence of antibiotic treatment in both 278 strain backgrounds (Fig. 5B) . Furthermore, transcription was hyperactivated in all three 279 prophages, including prophage 2 which showed no evidence of preferential DNA amplification 280 (compare Figs 4B and 5B). Higher expression levels were observed with prophage genes in the 281 gyrA R single mutant compared to WT (Fig. 5B ), and these levels were also apparent when 282 directly comparing transcription in WT and gyrA R after ciprofloxacin treatment (Fig. S3) . In 283 gyrA R -single mutants, enhanced expression in response to ciprofloxacin extended beyond the 284 prophage-chromosomal DNA junctions with prophage 1 and to some extent with prophage 3 285 ( Fig. 5C and S3 ), consistent with increased DNA template availability partially contributing to 286 heightened transcription in this strain background. Hyperexpression in response to ciprofloxacin 287 terminated at the prophage-chromosomal DNA junctions with prophage 2, consistent with the 288 observation that this region experienced no DNA amplification (Fig. 5C ). These results indicate 289 that preferential blockage of Topo IV in the single mutant results in hyperactivation of prophage 290 transcripts. 291
Intoxication of bacterial topoisomerase enzymes by fluoroquinolone antibiotics induces 292 DNA damage, driving an SOS response (16, 43) . We investigated the extent to which 293 ciprofloxacin-induced hyperactivation of prophage gene expression coincided with SOS 294 response induction, and whether gyrA or parC resistance alleles influenced this response. Several 295 genes associated with the SOS response (27, 43, 44) showed heightened transcription as a 296 consequence of ciprofloxacin treatment (Fig. 6A) . For several SOS genes, transcript induction 297 was significantly higher in gyrA R compared to WT ( Fig. 6A; asterisks) . These included genes 298 adjacent to prophage-chromosomal DNA junctions (umuC and umuD paralogs) as well as those 299 not directly linked to prophages (recA, gst; Fig. 6B ). RecA is a key component of the SOS 300 response that is induced by DNA damage in A. baumannii and is critical for withstanding 301 ciprofloxacin stress independent of the background resistance genotype (see Data Sets S1-S3). 302
To analyze the interplay of SOS induction by ciprofloxacin with target availability at the level of 303 single cells, we utilized a plasmid-based transcriptional fusion of the recA regulatory elements 304 (promoter and 5'-untranslated region) to the fluorescent reporter mKate2 (45). WT, gyrA R , and 305 gyrA R parC R strains harboring the reporter fusion were cultured in the presence of graded levels 306 of ciprofloxacin, and reporter signal was measured in individual cells by fluorescence 307 microscopy (Materials and Methods). Increasing sub-MIC doses of ciprofloxacin caused 308 increasing degrees of induction of the recA reporter in all strain backgrounds (Fig. 6C) . Notably, 309 reporter activity was approximately 2-fold higher in the gyrA R single mutant than in the WT or 310 double mutant at equivalent levels of growth inhibition (Fig. 6C ). Varying degrees of recA 311 induction within populations of gyrA R single mutant cells were observed, and this variability 312 roughly matched that observed with WT (Fig. S4) . Increased signal in the gyrA R strain was not 313 observed with a control reporter fusion to a gene that is nonresponsive to ciprofloxacin (trpBp-314 UTR) ((45), Fig 6D) , indicating that the SOS transcriptional response was specifically enhanced 315 as a consequence of ciprofloxacin inhibition of Topo IV. 316 317 Discussion 319
In this study we exploited the dual-target nature of fluoroquinolone antibiotics to uncover how 320 resistance alleles acquired in target enzymes modulate the landscape of intrinsic resistance. 321
Using Tn-seq, we performed comprehensive screens for determinants of resistance to the 322 fluoroquinolone drug ciprofloxacin in isogeneic A. baumannii strains in which the drug 323 preferentially targets either DNA gyrase or Topo IV. We found that the spectrum of genes 324 contributing to intrinsic resistance was similar in genetic backgrounds in which both enzymes 325 were WT or in which both enzymes had lowered drug sensitivity due to well-known acquired 326 point mutations. Intrinsic resistance determinants identified in both backgrounds included the 327
AdeIJK and AbeM efflux pumps, multiple subunits of the DNA recombination and repair 328 machinery, a periplasmic protease CtpA, the cell wall transpeptidase PBP1A, and several 329 proteins of unknown function. By contrast, interaction of ciprofloxacin with the gyrA R single 330 mutant in which Topo IV is the sensitive target dramatically altered the profile of genes that 331 influence relative Tn-seq fitness. This altered fitness profile in gyrA R parC + bacteria was shown 332 to directly reflect amplification of DNA in the vicinity of two endogenous prophages due to 333 preferential poisoning of Topo IV by ciprofloxacin. Prophage transcripts and the SOS pathway 334
were also hyperactivated as a consequence of this drug-genotype interaction, likely facilitating 335 the initiation of synthesis of prophage DNA in the gyrA R strain. 336
Our data can be explained by the model shown in Fig. 7 , if we assume that re-activation 337 of A. baumannii prophages 1 and 3 requires the function of host DNA gyrase. In WT and the 338 gyrA R parC R double mutant, DNA gyrase is the effective target blocked by ciprofloxacin at 339 growth-inhibitory, sub-MIC drug concentrations. Prophage DNA synthesis is blocked despite 340 induction of the DNA damage response and prophage gene transcription because, as postulated 341 by the model, efficient replication of the prophage genomes requires functional host gyrase (Fig.  342 7A and C). By contrast, in gyrA R bacteria, Topo IV is the preferred target of intoxication by 343 ciprofloxacin. This interaction causes DNA lesions that robustly stimulate the SOS pathway and 344 prophage transcription; further, host DNA gyrase is available to facilitate prophage genome 345 replication because the GyrA S81L (gyrA R ) variant is resistant to the intermediate concentrations 346
of ciprofloxacin required for Topo IV poisoning (Fig. 7B) . Therefore, the presence of the single 347 of DNA damage repair enzymes across all strain backgrounds (Data Sets S1-S3). We showed 365 that Topo IV intoxication stimulated the SOS pathway to a greater extent than that caused by 366 gyrase poisoning, potentially contributing to the robust activation of prophages. This is 367 consistent with previous findings that Topo IV and gyrase intoxication can be distinguished by 368 several characteristics. Topo IV lesions result in slower inhibition of DNA synthesis and are 369 thought to be more readily reversed by recombinational repair, resulting in lower cytotoxicity at 370 given drug concentrations (16). These less toxic lesions could potentially expose more numerous 371 or potent signals for the SOS response that could result in prophage induction. 372
In contrast with induction of prophages 1 and 3, ciprofloxacin-induced DNA replication 373 was not observed with prophage 2 despite activation of prophage gene transcription. One 374 possible explanation is that prophage 2 is defective for DNA replication. We consider this 375 unlikely because transposon insertions were unobtainable in a phage locus (ACX60_RS10145) 376 encoding a putative Cro/Cl family repressor (Data Sets S1-S3), indicating that this prophage has 377 the potential for lytic replication in the absence of a protein controlling lysogeny maintenance. 378
Consistent with the potential of all three prophages (including prophage 2) for replication, 379 mobilized DNA corresponding to each of the three prophages was detected in phage particles 380 resulting from treatment of WT A. baumannii 17978 with mitomycin C, which damages DNA 381 directly without dependence on interactions with DNA topoisomerases (44). An alternative 382 explanation for the lack of prophage 2 DNA amplification observed with fluoroquinolone 383 treatment in our study is that its replication depends on both DNA gyrase and Topo IV. 
Materials and Methods 413
Bacterial strains, growth conditions, and antibiotics. Bacterial strains used in this work are 414 described in Table S1 . A. baumannii strains were derivatives of ATCC 17978. Bacterial cultures 415 were grown at 37ºC in Lysogeny Broth (LB) (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) 416 in flasks with shaking or in tubes on a roller drum. Growth was monitored by measuring 417 absorbance at 600nm via a spectrophotometer. LB agar was supplemented with antibiotics 418
[ampicillin (Amp, 50-100 μg/ml), carbenicillin (Cb, 50-100 μg/ml), kanamycin (Km, 10-20 419 μg/ml), mecillinam, ciprofloxacin] or sucrose as needed (Sigma Aldrich). 420 421 Molecular cloning and mutant construction. Oligonucleotide primers and plasmids used in 422 this study are listed in Table S2 . Single gyrAS81L (gyrA R ) and parCS84L (parC R ) point 423 mutations were generated by cloning the respective genomic fragments in pUC18, followed by 424 inverse PCR and self-ligation or amplification and substitution of a mutated gene fragment. In-425 frame deletions of ciprofloxacin-resistance genes were generated as described (58). Constructs 426 were subcloned in pSR47S and used to isolate A. baumannii mutants via homologous 427 recombination with two selection steps (58). The gyrA R parC R double mutant was isolated by 428 selection of a derivative of the gyrA R strain able to grow on LB agar containing 8 µg/ml 429 ciprofloxacin. A pbp1a mutant (N178TfsX27) was isolated as a derivative of ATCC 17978 430 selected on LB agar containing 64 µg/ml mecillinam. Prep method (Illumina). 30ng of genomic DNA was used as input in a 10µl tagmentation 465 reaction. Reaction conditions were 55˚C for 5min followed by inactivation at 95˚C for 0.5min. 466
Transposon-adjacent genomic DNA was amplified by adding 40µl of PCR master mix 467 containing primers olj928 and Nextera 2A-R (0.6µM final) and Q5 High-Fidelity polymerase 468 (NEB). Reaction conditions were 98˚C for 10s, 65˚C for 20s, and 72˚C for 1min (30 cycles), 469 followed by a final extension at 72˚C for 2min. A second PCR was performed using nested, 470 indexed primers. This reaction contained 0.5µL of the first PCR reaction, Left Tn10 indexing 471 primer (0.6µM), Right indexing primer (0.6µM) and Q5 polymerase in a 50µl final volume. 472
Reaction conditions were 98˚C for 10s, 65˚C for 20s, and 72˚C for 1min (12 cycles of), followed 473 by a final extension at 72˚C for 2min. A sample of the second PCR product was imaged after 474 separation on a 2% agarose/TAE gel containing SYBR Safe dye. Samples were multiplexed 475 based on signal intensity in the 250-600bp region and purified (Qiagen QIAquick). 15-20pmol of 476 DNA was used as template in a 50µl reconditioning reaction containing adapter-specific primers 477 P1 and P2 (0.6µM) and Q5 polymerase. Reaction conditions were 95˚C for 1min, 0.1˚C/sec ramp 478 to 64˚C, 64˚C for 20s, 72˚C for 10min. Samples were purified (Qiagen QIAquick), followed by 479 quantification and size selection (250-600bp, Pippin HT) by the Tufts University Genomics Core 480 Facility (TUCF-Genomics). Libraries were sequenced (single-end 50bp) using custom primer 481 olk115 on a HiSeq2500 with High Output V4 chemistry at TUCF-Genomics. 482
483
Tn-seq data analysis. Reads were demultiplexed, quality-filtered and clipped of adapters before 484 serving as input for mapping and fitness calculations (31). Reads were mapped to the A. 485 baumannii 17978-mff chromosome (NZ_CP012004) and plasmids (NC_009083, NC_009084, 486 and NZ_CP012005) using previously described parameters (59). Fitness values for each 487 transposon mutant were calculated by comparing mutant vs population-wide expansion between 488 t 1 and t 2 (31). Per-gene average fitness and SD were then computed from fitness scores for all 489 insertion mutations within a gene across multiple parallel transposon pools. Differences in 490 average gene fitness between treated and untreated conditions (W diff ) were considered significant 491 if they fulfilled the following 3 criteria, with minor modification from those previously described 492 (33): per-gene fitness must be calculated from at least 3 data points, the magnitude of W diff must 493 be > 10%, and q value must be < 0.05 in an unpaired t-test with FDR controlled by the 2-stage 494 step-up method of Benjamini, Krieger and Yekutieli (GraphPad Prism 7). Per-insertion fitness 495 scores within a given genomic region were visualized using Integrative Genomics Viewer 496 software (60) after aggregating all scores across multiple independent transposon mutant 497 libraries using the SingleFitness Perl script (61). 498
499
Whole-genome sequencing of individual strains subjected to ciprofloxacin. WT, gyrA R , or 500 gyrA R parC R strains were grown from single colonies to early post-exponential phase and back-501 diluted to A 600 0.003. Parallel cultures were grown for 2.5 hours in the absence of treatment, or 502 3.5 hours in the presence of ciprofloxacin treatment. DNA was extracted (Qiagen DNeasy) and 503
Illumina sequencing libraries were amplified and sequenced as described (34). After mapping to 504 NZ_CP012004, coverage files were generated from the resulting BAM files using deepTools, 505 with reads normalized to counts per million (62). 506 507 Transcriptional profiling. Cultures were diluted to A 600 0.003 and grown for 2.5 hours 508 (untreated) or 3.5 hours (ciprofloxacin treated). Cultures were mixed with an equal volume of 509 ice-cold acetone:ethanol (1:1) and stored at -80ºC. Cells were thawed and washed with TE and 510 RNA was extracted (Qiagen RNeasy). RNA samples were diluted, combined with SUPERase-in 511 (Invitrogen), and processed via the RNAtag-seq method (42). Illumina cDNA sequencing 512 libraries were sequenced and reads processed as described (63). Differential expression was 513 calculated using DESeq2 (64). 514 515 Fluorescence reporter assays. Strains containing pCC1 or pCC7 were cultured in the presence 516 or absence of ciprofloxacin as in RNA-seq experiments. Cells were immobilized on agarose pads 517 and imaged on a Leica AF6000 microscope using a 100X/1.3 objective and TX2 filtercube 518 
